¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"bimolecular lamellar lipid membrane"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lipid solubility
    ÁöÁú¿ëÇØµµ
  • lipid storage disease
    ÁöÁúÃàÀûº´
  • lipid-soluble
    Áö¿ë¼º-
  • arachnoid membrane
    °Å¹Ì¸·, ÁöÁÖ¸·
  • atlanto-occipital membrane
    °í¸®µÚÅë¼ö¸·, ȯÃßÈĵθ·
  • acrosomal membrane
    ÷´Üü¸·
  • alveolar-capillary membrane
    ÆóÆ÷¸ð¼¼Ç÷°ü¸·, ÇãÆÄ²Ê¸®¸ð¼¼Ç÷°ü¸·
  • amnionic membrane
    ¾ç¸·
  • basement membrane
    ¹Ù´Ú¸·, ±âÀú¸·
  • basilar membrane
    ¹Ù´Ú¸·, ±âÀú¸·
  • buccopharyngeal membrane
    º¼Àεθ·
  • cloacal membrane
    ¹è¼³°­¸·
  • cricothyroid membrane
    ¹ÝÁö¹æÆÐ¸·, À±»ó°©»ó¸·
  • critical membrane potential
    ÀӰ踷ÀüÀ§
  • cell membrane
    ¼¼Æ÷¸·
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • synovial membrane
    À±È°¸·
  • tarsal membrane
    (¢¡orbital septum) ´«È®»çÀ̸·, ¾È¿Í°Ý¸·
  • urogenital membrane
    ºñ´¢»ý½Ä¸·
  • virginal membrane
    (¢¡hymen) ó³à¸·
  • premature rupture of membrane
    Á¶±â¾ç¸·ÆÄ¼ö, Á¶±â¾ç¸·ÆÄ¿­
  • membrane potential
    ¸·ÀüÀ§
  • membrane transport
    ¸·¿î¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lipid layer
    ÁöÁúÃþ
  • lipid pneumonia
    ÁöÁúÆó·Å
  • lipid proteinosis
    ÁöÁú´Ü¹éÁõ
  • lipid solubility
    ÁöÁú¿ëÇØµµ
  • acrosomal membrane
    ÷´Üü¸·
  • amnionic membrane
    ¾ç¸·
  • arachnoid membrane
    °Å¹Ì¸·
  • atlanto-occipital membrane
    °í¸®µÚÅë¼ö¸·
  • basement membrane
    ¹Ù´Ú¸·, ±âÀú¸·
  • buccopharyngeal membrane
    º¼Àεθ·
  • membrane bone
    ¸·»À
  • primary membrane bone
    ¼¼¸Á¼¶À¯¸·»À, ÀÏÂ÷¸·»À
  • reticulofibrous membrane bone
    (¢¡primary membrane bone) ¼¼¸Á¼¶À¯¸·»À, ÀÏÂ÷¸·»À
  • cell membrane
    ¼¼Æ÷¸·
  • cell membrane permeability
    ¼¼Æ÷¸·Åõ°ú¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Integral membrane protein
    ÅëÇÕ(÷Öùê) ¸·´Ü¹é(Ø­Ó±ÛÜ)
  • Lysosomal membrane
    ¶óÀ̼Ҽظ·(¡­Ø­)
  • POMP (principal outer membrane protein)
    ÁÖ¿ä¿Ü¸·´Ü¹éÁú
  • Reissners membrane
    ¶óÀ̽º³Ê ¸·
  • acid, membrane teichoic
    ¸·¼ºÅ¸ÀÌÄÚ»ê
  • acrosomal membrane
    ÷´Üü¸·
  • amnionic membrane
    ¾ç¸·.
  • anal membrane
    Ç×¹®¸·
  • antebrachial interosseous membrane
    ¾Æ·¡ÆÈ»À»çÀ̸·
  • anterior atlanto-occipital membrane
    ¾ÕȯÃßÈĵθ·, ÀüȯÃßÈĵθ·(îñü» õÐý­Ô騝
  • anterior atlanto-occipital membrane
    ¾Õ°í¸®µÚÅë¼ö¸·
  • anterior hyaloid membrane
    ¾ÕÀ¯¸®Ã¼¸·
  • anterior limiting membrane
    ¾Õ°æ°èÆÇ
  • anterior vitreous membrane
    ¾Õ(Àü)À¯¸®Ã¼¸·
  • artificial membrane
    Àΰø¸·(Àΰø¸·).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lamellar hole
    Ç¥Ãþ¿ø°ø, ºÒ¿ÏÀü¿ø°ø
  • lamellar ichthyosis
    ÆÇ»ó¾î¸°¼±
  • lamellar keratoplasty
    Ç¥Ãþ°¢¸·À̽Ä(¼ú)(öµßÒÊÇØ¯ì¹ãÕâú).
  • lamellar macular hole
    Ç¥ÃþȲ¹Ý¿ø°ø
  • lamellar membranous bone secondary membranous bone
    ÃþÆÇ¸·»À ÀÌÂ÷¸·»À
  • lamellar membranous boneÃþÆÇ¸·
    lamellar membranous boneÃþÆÇ¸·
  • lamellar process
    ÆÇµ¹±â
  • lamellar resection
    ÃþÆÇÀýÁ¦(¼ú)
  • lamellar retinal hole
    Ç¥Ãþ¸Á¸·¿­°ø
  • lamellar sheath =perineurium
    Ãþ»óÃÊ(öµßÒôú).
  • blood lipid
    Ç÷¾×ÁöÁú(úìäûò·òõ).
  • fecal lipid
    ºÐº¯Áö¹æ
  • free radical formation,lipid peroxidation
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, ÁöÁú °ú»êÈ­(ò·òõ Φ߫ûù)
  • granule, lipid
    Áö¹æ°ú¸³
  • lipid
    ÁöÁú(ò·òõ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Tympanic membrane
    °í¸·
    [¿¾ ¿ë¾î] °í¸·
  • Tympanic membrane
    °í¸· [±Íû]
    [¿¾ ¿ë¾î] °í¸·
  • Tympanic membrane
    °í¸· [±Íû]
    [¿¾ ¿ë¾î] °í¸·º®
  • Branches to tympanic membrane
    °í¸·°¡Áö
    [¿¾ ¿ë¾î] °í¸·Áö
  • Umbo of tympanic membrane
    °í¸·¹è²Å
    [¿¾ ¿ë¾î] °í¸·Á¦
  • Recesses of tympanic membrane
    °í¸·¿À¸ñ
    [¿¾ ¿ë¾î] °í¸·ÇÔ¿ä
  • Tympanic wall [Spiral membrane]
    °í½Ç°è´Üº® [³ª¼±¸·]
    [¿¾ ¿ë¾î] °í½Çº®
  • Tympanic wall of cochlear duct [Spiral membrane]
    °í½Ç°è´Üº® [³ª¼±¸·]
    [¿¾ ¿ë¾î] °í½Ç°èº®
  • Mucous membrane of tympanic cavity
    °í½ÇÁ¡¸·
    [¿¾ ¿ë¾î] °í½ÇÁ¡¸·
  • Reticular membrane
    ±×¹°¸·
    [¿¾ ¿ë¾î] ¼¼¸Á¸·
  • Vitelline membrane
    ³­È²¸·
    [¿¾ ¿ë¾î] ³­È²¸·
  • Endothelioendothelial membrane
    ³»ÇÇ»çÀ̸·
    [¿¾ ¿ë¾î] ³»Çǰ£¼ºÇ÷°£°³À縷
  • Endotheliochorial membrane
    ³»ÇÇÀ¶¸ð¸·
    [¿¾ ¿ë¾î] ³»ÇÇÀ¶¸ð¸·¼ºÇ÷°£°³À縷
  • Quadrangular membrane
    ³×¸ð¸·
    [¿¾ ¿ë¾î] »ç°¢¸·
  • Periventricular glial limiting membrane
    ³ú½ÇÁÖÀ§¾Æ±³°æ°è¸·
    [¿¾ ¿ë¾î] ³ú½ÇÁÖÀ§°æ°è¸·
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lipid-globular protein mosaic model
    "ÁöÁú-±¸»ó´Ü¹éÁú(ò·òõϹßÒÓ±ÛÜòõ) , ¸ðÀÚÀÌÅ©¸ðµ¨"
  • lipid imbibition theory
    ÁöÁúÈí¼öÀÌ·Ð(ò·òõýåâ¥ìµÖå)
  • lipid intermediate
    ÁöÁúÁß°£´ë»ç¹°(ò·òõñéÊàÓÛÞóÚª)
  • lipid mobilization
    ÁöÁúµ¿¿ø(ò·òõÔÑê¬)
  • lipid peroxidation
    ÁöÁú°ú»êÈ­(ò·òõΦ߫ûù)
  • lipid-soluble vitamin
    Áö¿ë¼º(ò·éÁàõ)ºñŸ¹Î
  • lipid solvent
    ÁöÁú¿ë¸Å(ò·òõéÁØÚ)
  • lipid storage disease
    ÁöÁúÀúÀåÁúȯ(ò·òõîÍíúòðü´)
  • lipid vesicle
    ÁöÁú¼ÒÆ÷(ò·òõá³øÐ)
  • low-lipid lipoprotein
    ÀúÁöÁú Áö´Ü¹éÁú(î¸ò·òõò·Ó±ÛÜòõ)
  • neutral lipid
    Áß¼ºÁöÁú(ñéàõò·òõ)
  • nonsaponifiable lipid
    ºñ(Þª)ºñ´©È­ ÁöÁú(ò·òõ)
  • polar lipid
    ±Ø¼º ÁöÁú(пàõò·òõ)
  • redox lipid
    ·¹µ¶½º ÁöÁú(ò·òõ)
  • saponifiable lipid
    °¡(ʦ)ºñ´©È­ ÁöÁú(ò·òõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LKP lamellar keratoplasty
LM lactic acid mineral [medium]; lactose malabsorption; laryngeal mask; laryngeal muscle; lateral malle...
PROM   1) Premature Rupture of Amniotic Membrane; < Labor Onset
  2) Preterm Ruptu...
BM Bachelor of Medicine; barium meal; basal medium; basal metabolism; basement membrane; basilar membra...
CM California mastitis [test]; calmodulin; capreomycin; carboxymethyl; cardiac murmur; cardiac muscle; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BLM Bilayer lipid membrane
BLM black lipid membrane
MLA 4'-Monophosphoryl lipid A
ALBP Adipocyte lipid binding protein
ABLC Amphotericin B Lipid Complex
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lamellar retinal hole
    Ç¥Ãþ ¸Á¸· ¿­°ø
  • antibasement membrane antibody
    Ç×±âÀú¸· Ç×ü
  • arachnoid membrane
    °Å¹Ì¸·
    ³ú¿Í ô¼ö¸¦ µÑ·¯½Ñ ¼¼ ÃþÀÇ ¸· Áß Áß°£Ãþ.
  • autoantibody against basement membrane
    Ç×±âÀú¸· ÀÚ°¡ Ç×ü
  • basal membrane of semicircular canal
    ¹Ý±Ô°ü ±âÀú¸·, ¹Ý°í¸®°ü ¹Ù´Ú ¸·
  • basilar membrane
    ±âÀú ¸·
  • benign mucous membrane pemphigoid
    ¾ç¼º Á¡¸· À¯ÃµÆ÷â
  • biological membrane
    »ýü ¸·
    ¼¼Æ÷ ¶Ç´Â ¼¼Æ÷ ¼Ò±â°üÀÇ °ÑÀ» ½Î°í ÀÖ´Â ¸·. ¹Ì»ý¹°, ½Ä¹°, µ¿¹°ÀÇ ¼¼Æ÷¸·°ú ¿±·Ïü, ¹ÌÅäÄܵ帮¾ÆÀÇ ³», ¿Ü¸·, °ñÁöü, ¼ÒÆ÷ü ¸·, ÇÙ¸· µîÀÌ º¸±âÀÌ´Ù. »ýü¸·ÀÇ ±¸Á¶¿¡ °üÇÑ ¸ðµ¨Àº ¿©·¯ °¡Áö°¡ Á¦½ÃµÇ¾úÀ¸³ª °áÁ¤ÀûÀÎ °ÍÀº ¾ø´Ù. ¿ª»çÀûÀ¸·Î º¼ ¶§ J.F. ´Ù´Ï¿¤ ¸®°¡ Á¦Ã¢Çϰí J.D. ·Î¹öÆ®½¼¿¡ ÀÇÇØ ¼öÁ¤µÈ ´ÜÀ§¸· ¸ðµ¨ÀÌ ÀÖÀ¸¸ç, ±× ÈÄ B. º¥¼Õ µî¿¡ ÀÇÇØ Á¦Ã¢µÈ ¹Ýº¹ ´ÜÀ§ ¸ðµ¨ÀÌ ÀÖ´Ù. ÇöÀç ³Î¸® ÀÎÁ¤¹Þ°í ÀÖ´Â °ÍÀ¸·Î´Â 1972³â S.J. ½Ì°Å µîÀÌ Á¦Ã¢ÇÑ À¯µ¿ ¸ðÀÚÀÌÅ© ¸ðµ¨ÀÌ ÀÖ´Ù. ¸·ÀÇ ÁÖ ¼ººÐÀº ´Ü¹éÁú°ú ÁöÁúÀÌ¸ç µÎ ¼ººÐÀÇ Áß·®ºñ´Â 3:2~3:1·Î ´Ü¹éÁúÀÌ ¸¹´Ù. ÁöÁúÀÇ ÁÖ ¼ººÐÀº ÀÎÁöÁúÀÌ¸ç »ýü¸·ÀÇ ¼ººÐÀ¸·Î ´Ù´ç·ùµµ ¾à°£ Á¸ÀçÇÑ´Ù. ¸·ÀÇ ±¸¼º ¼ººÐÀÎ ÀÎÁöÁú ºÐÀÚ´Â ÀϺκп¡ Ä£¼ö¼º±â¸¦ °¡Áø °¡´À´Ù¶õ ºÐÀڷμ­, ±× ±ä ÃàÀÌ ¸·¸é°ú Á÷°¢À¸·Î ´Ã¾î¼­ ÀÖ°í ¼Ò¼ö¼º ºÎºÐÀÌ ¸¶ÁÖº¸°í ÀÖ¾î 2ºÐÀÚ µÎ²²ÀÇ ¸·À» ¸¸µç´Ù. ´Ü¹éÁúÀº ÁÖ·Î ±¸»ó ´Ü¹éÁúÀ̸ç, ÀÌ ÁöÁú ÀÌÁßÃþ ¼Ó¿¡ ´Ü¹éÁúÀÇ ¼Ò¼ö¼º ºÎºÐÀÌ Àá°Ü ÀÖµíÀÌ Á¸ÀçÇÑ´Ù. ¾î¶² °ÍÀº ¸·ÀÇ ¾ç¸é¿¡ ºÐÀÚÀÇ ÀϺκÐÀ» µå·¯³»°í ÀÖ´Ù. ÀÌ °á°ú ¸·Àº ÁöÁú°ú ´Ü¹éÁúÀÌ ¸ðÀÚÀÌÅ© »óÀ¸·Î Á¸ÀçÇÏ´Â ±¸Á¶°¡ µÈ´Ù. ÁöÁúÀº »ý¸®Àû ¿Âµµ¿¡¼­´Â ¾×üÀ̱⠶§¹®¿¡ ¸· ¼ººÐÀÎ ´Ü¹éÁúÀº ºñ±³Àû ÀÚÀ¯·Ó°Ô ¸·³»¸¦ À̵¿
  • bowmans membrane
    ¾Õ°æ°èÆÇ
  • bucconasal membrane
    ±¸ºñ¸·
  • buccopharyngeal membrane
    ÇùÀεΠ¸·
  • cell membrane permeability
    ¼¼Æ÷¸· Åõ°ú¼º
  • cellular membrane
    ¼¼Æ÷¼º ¸·
    ¼¼Æ÷ÀÇ Ç¥¸éÀ» µ¤°Å³ª °øµ¿ÀÇ ³»¸éÀ» µ¤´Â, ¶Ç´Â °ø°£À̳ª ±â°üÀ» ³ª´©´Â ¾ãÀº ÃþÀÇ Á¶Á÷.
  • cellulose membrane
    ¼¿·ê·Î½º ¸·
  • chorioallantoic membrane inoculation
    À¶¸ð ¿ä¸· Á¢Á¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
neutral lipid storage disease <syndrome> Congenital ichthyosis, leukocyte vacuoles, and variable involvement of other organ systems.
Synonym: neutral lipid storage disease.
(05 Mar 2000)
disease, lipid storage A series of disorders due to inborn errors in lipid metabolism resulting in the abnormal accumulation of lipids in the wrong places (Examples include Gaucher, Fabry and Niemann-Pick diseases and metachromatic leukodystrophy).
(12 Dec 1998)
inositol lipid A membrane-anchored phospholipid that transduces hormonal signals by stimulating the release of any of several chemical messengers.
(09 Oct 1997)
isotropic lipid A lipid occurring in the form of singly refractive droplets.
(05 Mar 2000)
lipid <chemical> Any of a heterogeneous group of flats and fatlike substances characterised by being water insoluble and being extractable by nonpolar (or fat) solvents such as alcohol, ether, chloroform, benzene, etc. All contain as a major constituent aliphatic hydrocarbons. The lipids, which are easily stored in the body, serve as a source of fuel, are an important constituent of cell structure and serve other biological functions. Lipids may be considered to include fatty acids, neutral fats, waxes and steroids. Compound lipids comprise the glycolipids, lipoproteins and phospholipids.
(18 Nov 1997)
lipid A The lipid associated with polysaccharide in the lipopolysaccharide of gram-negative bacterial cell walls.
(18 Nov 1997)
lipid A 4'-phosphatase <enzyme> Involved in lipid a biosynthesis in rhizobium leguminosarum
Registry number: EC 3.1.3.-
Synonym: 2-keto-3-deoxyoctulosonate-activated 4'-phosphatase, kdo-activated lipid a 4'-phosphatase
(26 Jun 1999)
lipid A disaccharide synthase <enzyme> Udp-diacyl-n-acetylglucosamine plus 2,3-diacyl-n-acetylglucosamine-1-phosphate yields 2',3'-diacyl-glcn-(beta 1-6)-2,3-diacyl-glcn-1-p plus udp
Registry number: EC 2.4.1.182
Synonym: 2,3-diacyl-n-acetylglucosamine diacyl-n-acetylglucosaminyltransferse, lipid a synthase
(26 Jun 1999)
lipid bilayer <biochemistry> A lamellar organisation of phospholipids that are packed as a bilayer with hydrophobic acyl tails inwardly directed and polar head groups on the outside surfaces.
It is this bilayer that forms the basis of membranes in cells, though in most cellular membranes a very substantial proportion of the area may be occupied by integral proteins. The triple layered appearance of membranes seen in electron microscopy is thought to arise because the osmium tetroxide binds to the polar regions leaving a central, unstained, hydrophobic region.
(31 Dec 1997)
lipid bilayers Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes.
(12 Dec 1998)
lipid granulomatosis <dermatology, pathology> An accumulation of an excess of lipids in the body due to disturbance of lipid metabolism and marked by the formation of foam cells in skin lesions.
(16 Dec 1997)
lipid histiocytosis Histiocytosis with cytoplasmic accumulation of lipid, either phospholipid (Niemann-Pick disease) or glucocerebroside (Gaucher's disease).
(05 Mar 2000)
lipid keratopathy Occurrence of fats in an area of corneal vascularization.
(05 Mar 2000)
lipid mobilization The breakdown of stored triglyceride in adipose tissue with the release of free fatty acids and glycerol. Depot fat hydrolysis is catalyzed by a lipase in response to pituitary lipid mobilization factors (lmf), various hormones, serotonin, or hepatotoxins such as carbon tetrachloride.
(12 Dec 1998)
lipid-mobilizing hormone <protein> Polypeptide hormone (_ form: 9894D, 91 residues, _ form has only residues 1-58 of _) from the pituitary hypophysis, that is of particular interest because it is the precursor of endorphins, which are released by proteolysis. Promotes lipolysis and acts through the adenylyl cyclase system. Part of the ACTH group of hormones.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á